本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

TransCode Therapeutics Inc.

0.3000
+0.027510.09%
盘后0.2972-0.0028-0.93%18:23 EDT
成交量:1,329.28万
成交额:444.40万
市值:700.24万
市盈率:0.00
高:0.3850
开:0.2784
低:0.2784
收:0.2725
数据加载中...
2024/06/21

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2024/06/14

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/06/13

重要事件披露

Form 8-K - Current report
2024/06/07

重要事件披露

Form 8-K - Current report
2024/05/15

重要事件披露

Form 8-K - Current report
2024/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/10

重要事件披露

Form 8-K - Current report
2024/04/23

重要事件披露

Form 8-K - Current report
2024/04/05

重要事件披露

Form 8-K - Current report
2024/04/01

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/31

重要事件披露

Form 8-K - Current report
2024/01/22

重要事件披露

Form 8-K - Current report
2024/01/18

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/01/17

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/01/17

SEC问询函

Form CORRESP - Correspondence
2024/01/17

SEC问询函

Form CORRESP - Correspondence
2024/01/17

重要事件披露

Form 8-K - Current report